Cancer Family
Breast Neoplasm
CI-CAN-00000007Explore in graph →
Non-malignant2,895 active trials43 approved drugs310 evidence items
- NCIt
- C2910
- OncoTree
- BNNOS
- MeSH
- D000069584
- MeSH
- D001943
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000007Explore in graph →
Clinical trials
13,871 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05704842 | Evaluate Impact of Exercise Program on Fatigue in Breast Cancer During Chemotherapy | unknown | N/A | 40 | Virtua Health, Inc.OTHER | 1 | Apr 5, 2024 | clinicaltrials |
| NCT06348654 | New Digital Person-based Care Model in Patients With HER2-negative Advanced Breast Cancer(InPERSON) | unknown | — | 50 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 0 | Apr 5, 2024 |
| clinicaltrials |
| NCT06346457 | Breast Cancer & Antiestrogenic Therapy & Brain | unknown | — | 180 | International Research Training Group 2804OTHER | 1 | Apr 4, 2024 | clinicaltrials |
| NCT06182306 | Prospective Evaluation of AI R&D Tool for Patient Stratification - MoA Evaluation in Triple Negative Breast Cancer (PEAR-MET)(PEAR-MET) | unknown | — | 30 | Ourotech, Inc.INDUSTRY | 1 | Apr 3, 2024 | clinicaltrials |
| NCT06341842 | Potential Protective Role of SGLT-2 Inhibitors for Chemotherapy-induced Cardiotoxicity(PROTECT) | unknown | Phase 2 | 316 | Fondazione IRCCS Policlinico San Matteo di PaviaOTHER | 1 | Apr 2, 2024 | clinicaltrials |
| NCT06343181 | A Qualitative Study on Treatment Adherence in Patients With Metastatic Breast Cancer | unknown | — | 20 | European Institute of OncologyOTHER | 1 | Apr 2, 2024 | clinicaltrials |
| NCT05311618 | Study of NGM438 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumors | unknown | Phase 1 | 71 | NGM Biopharmaceuticals, IncINDUSTRY | 1 | Apr 1, 2024 | clinicaltrials |
| NCT06340165 | A Real-world Efficacy and Safety Study of Amlotinib for HER2-negative Advanced Breast Cancer | unknown | — | 153 | The First Hospital of Jilin UniversityOTHER | 1 | Apr 1, 2024 | clinicaltrials |
| NCT06340386 | Italian Validation of a Tool for Assessing Sexual Function After Breast Cancer, FSFI-BC | unknown | — | 600 | European Institute of OncologyOTHER | 1 | Apr 1, 2024 | clinicaltrials |
| NCT06338605 | Evaluating the Incidence of Pseudo-Acute Kidney Injuries in Patients With Metastatic Breast Cancer on CDK4/6 Inhibitors Trough Cystatin C Analysis(CYSTATINcDK4/6) | unknown | — | 40 | Erasmus Medical CenterOTHER | 1 | Mar 29, 2024 | clinicaltrials |
| NCT06338644 | Palbociclib in Metastatic Breast Cancer: Gene Polymorphism-based Study in Egyptian Patients.(Palbociclib) | unknown | — | 100 | Helwan UniversityOTHER | 0 | Mar 29, 2024 | clinicaltrials |
| NCT06334445 | CARDIOCARE Prospective Clinical Study(CARDIOCARE) | unknown | — | 736 | European Institute of OncologyOTHER | 1 | Mar 28, 2024 | clinicaltrials |
| NCT06332976 | PrefeRences And ChemoTherapy In Breast Cancer patiEnts(PRACTICE) | unknown | — | 450 | European Institute of OncologyOTHER | 1 | Mar 27, 2024 | clinicaltrials |
| NCT06327438 | Effect of Complex Decongestive Therapy, Cryotherapy and Kinesio Taping in Patients With Post-mastectomy Lymphedema: A Randomized Control Trial | unknown | N/A | 60 | South Valley UniversityOTHER | 1 | Mar 25, 2024 | clinicaltrials |
| NCT06327607 | Psychosexuological Interventions to Support Sexual Function in Breast Cancer Patients | unknown | — | 82 | European Institute of OncologyOTHER | 1 | Mar 25, 2024 | clinicaltrials |
| NCT06328387 | HCQ+ADC vs ADC in the Treatment of Advanced Breast Cancer | unknown | Phase 1 / Phase 2 | 120 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Mar 25, 2024 | clinicaltrials |
| NCT06329089 | Reoperative Sentinel Lymph Node Biopsy in Patients With Recurrent Ipsilateral Breast Cancer(RENATA) | unknown | — | 97 | Hospital Clinic of BarcelonaOTHER | 1 | Mar 25, 2024 | clinicaltrials |
| NCT00382070 | Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer | unknown | Phase 3 | 3,966 | NSABP Foundation IncNETWORK | 3 | Mar 22, 2024 | clinicaltrials |
| NCT03423199 | PAlbociclib Plus Tamoxifen for the Treatment of Hormone Receptor-positive, HER2-negative Advanced Breast Cancer Women - Asian studY(PATHWAY) | unknown | Phase 3 | 180 | National Cancer Center, JapanOTHER_GOV | 4 | Mar 22, 2024 | clinicaltrials |
| NCT06317948 | Improving the Quality of Radiotherapy by Multi-Institution Knowledge-Based Planning Optimization Models (Acronym: MIKAPOCo, Multi-Institutional Knowledge-based Approach in Plan Optimization for the Community)(MIKAPOCo) | unknown | — | 1,000 | IRCCS Ospedale San RaffaeleOTHER | 1 | Mar 20, 2024 | clinicaltrials |
| NCT06321640 | Study for the Multidimensional Analyses of Resistance and Toxicity to Immune- and Targeted-therapies.(POSITive) | unknown | — | 265 | European Institute of OncologyOTHER | 1 | Mar 20, 2024 | clinicaltrials |
| NCT06321666 | Response Evaluation of Cancer Therapeutics in Metastatic Breast Cancer to the Bone(RESPECT-MI) | unknown | N/A | 58 | European Institute of OncologyOTHER | 1 | Mar 20, 2024 | clinicaltrials |
| NCT06319209 | Timing of Surgery and the Evolution of Postoperative Outcomes in Breast Cancer Patients Undergoing Surgical Intervention Following Recovery From SARS-CoV-2 Infection | unknown | — | 392 | Fujian Medical University Union HospitalOTHER | 1 | Mar 19, 2024 | clinicaltrials |
| NCT05907941 | ciNPT in Autologous DIEP Flap Breast Reconstruction | unknown | N/A | 114 | McMaster UniversityOTHER | 0 | Mar 15, 2024 | clinicaltrials |
| NCT06313073 | Neoadjuvant Radiotherapy for Breast Cancer | unknown | N/A | 60 | Changhai HospitalOTHER | 1 | Mar 15, 2024 | clinicaltrials |
| NCT06313476 | AMH Predicts Postchemotherapy Menopause in Premenopausal Breast Cancer Patients | unknown | — | 153 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 0 | Mar 15, 2024 | clinicaltrials |
| NCT06096545 | Axillary Management After Neoadjuvant Chemotherapy | unknown | N/A | 50 | Medipol UniversityOTHER | 1 | Mar 13, 2024 | clinicaltrials |
| NCT06308939 | Eribulin Combined With Sintilimab as First-line Treatment for Unresectable Locally Advanced or Metastatic HER2-negative Breast Cancer:A Multicenter, Single-arm,Phase II Clinical Trial | unknown | Phase 2 | 81 | Zhejiang Cancer HospitalOTHER | 1 | Mar 13, 2024 | clinicaltrials |
| NCT03442504 | Prediction of Response to 2nd-line Hormone Therapy by FES CT/PET in Patients With Metastatic Breast Cancer(TEP-FES) | unknown | N/A | 57 | Institut Cancerologie de l'OuestOTHER | 1 | Mar 12, 2024 | clinicaltrials |
| NCT05861830 | Dalpiciclib With Endocrine Therapy for Advanced Breast Cancer After CDK4/6 Inhibitor Failure (DAWNA-FES) | unknown | Phase 3 | 80 | Peking Union Medical College HospitalOTHER | 1 | Mar 12, 2024 | clinicaltrials |
| NCT06300099 | Dexamethasone Versus Dexmedetomidine as Adjuncts to Serratus Anterior Plane Block | unknown | Phase 4 | 126 | Al-Azhar UniversityOTHER | 0 | Mar 12, 2024 | clinicaltrials |
| NCT06164119 | Effects of Diet and Osteopathy on Quality of Life and Inflammation in Breast Cancer Patients Under Hormonal Therapy(SECCO) | unknown | N/A | 600 | Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoOTHER | 1 | Mar 8, 2024 | clinicaltrials |
| NCT06251401 | Cardiac Rehabilitation for Breast Cancer Survivors | unknown | N/A | 50 | Women's College HospitalOTHER | 1 | Mar 8, 2024 | clinicaltrials |
| NCT03580109 | Spa Therapy for Upper or Lower Limb Lymphoedema(THERMOEDEME) | unknown | N/A | 160 | Association Francaise pour la Recherche ThermaleOTHER | 1 | Mar 6, 2024 | clinicaltrials |
| NCT04904653 | The Effectiveness of Hemopatch® in the Reduction of Post-surgical Serous Drainage | unknown | Phase 4 | 118 | Instituto de Investigación Hospital Universitario La PazOTHER | 1 | Mar 6, 2024 | clinicaltrials |
| NCT06103318 | eHealth Interventions for Breast Cancer Cognitive Impairment(ICOgnition) | unknown | N/A | 176 | Institut Català d'OncologiaOTHER | 0 | Mar 6, 2024 | clinicaltrials |
| NCT04739670 | Evaluating the Efficacy and Safety of Bevacizumab, Carboplatin, Gemcitabine and Atezolizumab in Breast Cancer(BELLA) | unknown | Phase 2 | 31 | Peter MacCallum Cancer Centre, AustraliaOTHER | 1 | Mar 1, 2024 | clinicaltrials |
| NCT06288620 | Microwave Ablation in the Treatment of Early-stage Unifocal Invasive Breast Cancer | unknown | N/A | 77 | The First Affiliated Hospital with Nanjing Medical UniversityOTHER | 1 | Mar 1, 2024 | clinicaltrials |
| NCT04906330 | Oncoliq: Test for Early Breast Cancer Detection. | unknown | — | 500 | Hospital Militar Central Cirujano Mayor Dr. Cosme ArgerichOTHER | 1 | Feb 28, 2024 | clinicaltrials |
| NCT05033925 | Ficus Septica Leaves Fraction as a Complementary Therapy for Stadium IV Breast Cancer Patients | unknown | Phase 1 / Phase 2 | 324 | Gadjah Mada UniversityOTHER | 1 | Feb 28, 2024 | clinicaltrials |
| NCT05474391 | MammaPrint Value for Pre-menopausal Breast Cancer Patients | unknown | — | 200 | Fudan UniversityOTHER | 1 | Feb 26, 2024 | clinicaltrials |
| NCT05574881 | Dalpiciclib, Fulvestrant, Trastuzumab and Pertuzumab in HR Positive, HER2 Positive Metastatic Breast Cancer | unknown | Phase 1 / Phase 2 | 72 | Fudan UniversityOTHER | 1 | Feb 26, 2024 | clinicaltrials |
| NCT06276439 | Intraoperative Imaging of Lymph Nodes | unknown | — | 48 | University of Illinois at Urbana-ChampaignOTHER | 1 | Feb 26, 2024 | clinicaltrials |
| NCT05949333 | Reducing Neutropenia Incidence With Pegfilgrastim Administration on Day 3 After Chemotherapy(NEUTHREE) | unknown | Phase 4 | 100 | Eunseong Medical Foundation Good GANG-AN HOSPITALOTHER | 1 | Feb 23, 2024 | clinicaltrials |
| NCT06275321 | Physical Exercise Benefits for Cancer Patients | unknown | N/A | 60 | Universitat Jaume IOTHER | 1 | Feb 23, 2024 | clinicaltrials |
| NCT03474822 | Plasmodium Immunotherapy for Breast and Liver Cancers | unknown | Phase 1 / Phase 2 | 60 | CAS Lamvac Biotech Co., Ltd.INDUSTRY | 1 | Feb 20, 2024 | clinicaltrials |
| NCT03500380 | A Study of RC48-ADC Administered Intravenously to Patients With HER2-Positive Metastatic Breast Cancer With or Without Liver Metastases | unknown | Phase 2 / Phase 3 | 301 | RemeGen Co., Ltd.INDUSTRY | 1 | Feb 20, 2024 | clinicaltrials |
| NCT05711030 | Thoracic Paravertebral Block Anesthesia for Breast Cancer Surgery(TPVB) | unknown | N/A | 68 | Ciusss de L'Est de l'Île de MontréalOTHER | 1 | Feb 20, 2024 | clinicaltrials |
| NCT03924466 | Repeatability of 68-GaNOTA-Anti-HER2 VHH1 PET/CT in Breast Carcinoma Patients(VUBAR) | unknown | Phase 2 | 55 | Universitair Ziekenhuis BrusselOTHER | 1 | Feb 16, 2024 | clinicaltrials |
| NCT06261918 | Transcriptional and Epimetabolic Profile of Breast Carcinoma With Luminal or HER2+ or Locally Advanced Triple-negative Histotype in Patients With/Without Previous Clinical History of Metabolic Syndrome(PROMETA) | unknown | — | 120 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Feb 15, 2024 | clinicaltrials |
Data updated 23 days agoSource updated Apr 5, 2024source: clinicaltrials